LabVantage Solutions announced the United States Army Medical Research Acquisition Activity (USAMRAA) has awarded the company a contract to supply its LabVantage Pharma laboratory information management system (LIMS) to the Walter Reed Army Institute of Research (WRAIR). WRAIR will use LabVantage Pharma to support vaccine production programs for COVID-19 and other diseases at its Pilot Bioproduction Facility.
“We developed LabVantage Pharma to make it fast and easy for pharmaceutical and biotech organizations to acquire and implement a state-of-the-art laboratory information management system to enable efficient and compliant quality manufacturing,” said John Heiser, CEO of LabVantage. “We appreciate that WRAIR understood the unique benefits of LabVantage Pharma and moved to expedite its acquisition via a sole source contract. We are very proud that our purpose-built LIMS is now helping the WRAIR address the urgent need for new vaccines and therapies to combat COVID-19 and other serious diseases.”
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
LabVantage Pharma is pre-validated according to GAMP 5 guidelines, which greatly shortens the implementation process and reduces overall cost and risk. It complies with Title 21 CFR Part 11 regulatory requirements and is developed, tested, and maintained using a quality system based on IEEE standards for software quality. LabVantage Pharma facilitates the ability of laboratory administrators to manage the sample lifecycle, optimize laboratory execution, perform data retrieval, interface instruments and systems, and enable security and auditing. LabVantage provides comprehensive customer services, including system installation and setup, individualized methods and specifications, and personnel training.